AbbVie
ABBV
#31
Rank
$322.43 B
Marketcap
$182.10
Share price
0.97%
Change (1 day)
15.07%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2023 (TTM): $6.25 B

According to AbbVie's latest financial reports the company's current earnings (TTM) are $6.25 B. In 2022 the company made an earning of $13.47 B an increase over its 2021 earnings that were of $12.98 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2023

Annual earnings

Year Earnings Change
2023 (TTM)$6.25 B-53.62%
2022$13.47 B3.76%
2021$12.98 B282.25%
2020$3.39 B-59.67%
2019$8.42 B62.13%
2018$5.19 B-32.74%
2017$7.72 B-1.99%
2016$7.88 B18.65%
2015$6.64 B180.5%
2014$2.36 B-55.57%
2013$5.33 B-6.86%
2012$5.72 B56.05%
2011$3.66 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$3.26 B-47.73%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.55 B 4.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.85 B 25.68%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.29 B-79.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.85 B 9.74%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.44 B 35.04%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.49 B 35.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
$7.53 B 20.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
$0.33 B-94.61%๐Ÿ‡บ๐Ÿ‡ธ USA